Biotech · Public company · Houston, TX, US
Coya Therapeutics, Inc.
Ticker COYA · SEC CIK 0001835022
Track this companyFree. Adds Coya Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- COYA 302Phase 3 · Amyotrophic Lateral Sclerosis (ALS)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Study of COYA 302 for the Treatment of ALSPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Oct 1, 2025ClinicalTrials.gov NCT07161999 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 15, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 8-K/A · 8-K/ASEC EDGAR · filed Aug 7, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 25, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026